trial · primary record
Laboratory Biomarker Analysis
Locally Advanced Breast Carcinoma
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-04-20 |
| Primary endpoint | Percent of Participants With Grade 2-5 Toxicity Using National Cancer Institute Common Toxicity Criteria Version 4.0 |
| Registry ID | NCT01463072 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.998Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01463072
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Laboratory Biomarker Analysis · compound